Compare BLKB & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLKB | STAA |
|---|---|---|
| Founded | 1981 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Ophthalmic Goods |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2004 | 1995 |
| Metric | BLKB | STAA |
|---|---|---|
| Price | $47.20 | $22.93 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $50.00 | $22.81 |
| AVG Volume (30 Days) | 579.0K | ★ 918.2K |
| Earning Date | 04-29-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 142.32 | N/A |
| EPS | ★ 1.46 | 0.26 |
| Revenue | N/A | ★ $239,442,000.00 |
| Revenue This Year | $6.26 | $30.82 |
| Revenue Next Year | $4.25 | $8.41 |
| P/E Ratio | ★ $32.25 | $87.92 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $25.58 | $15.59 |
| 52 Week High | $70.71 | $35.87 |
| Indicator | BLKB | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 68.72 | 37.90 |
| Support Level | $45.83 | $21.70 |
| Resistance Level | $50.76 | $26.21 |
| Average True Range (ATR) | 1.82 | 1.16 |
| MACD | -0.25 | -0.08 |
| Stochastic Oscillator | 89.16 | 2.24 |
Founded in 1981, Blackbaud provides software solutions designed to serve the "social good" community, including nonprofits, foundations, corporations, educational institutions, healthcare institutions, and individual change agents. Through M&A and organic product development efforts, the company has also moved into related areas outside core fundraising, notably into K-12 schools. The firm enables more than $100 billion in donations annually across a customer base in excess of 40,000 customers in over 100 countries.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.